Lumen Technologies is experiencing a share price surge driven by AI technology demands, despite a decline in third-quarter revenue and EBITDA. The company's operating cash flow surged to $3.6 ...
The purpose of this study was to optimize the growth and testing conditions for Acanthamoeba to maximize amoeba viability and allow for the testing of a more realistic solution efficacy against ...
The company hasn’t set a specific date for when the new 3D lens will be available, but it says it will be sometime in November 2024, with an “estimated retail price” of $449.99. That’s ...
Lumen (LUMN) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.09 per share a year ago. These figures are ...
2024 Free Cash Flow Guidance: Raised to $1.2 billion to $1.4 billion. Lumen Technologies Inc (NYSE:LUMN) has secured over $8 billion in Private Connectivity Fabric (PCF) sales, indicating strong ...
Megan E. Shoff, Ph.D.; Malvina B. Eydelman, M.D. To obtain an axenic culture of CDC-V568, cultures were grown on NNAS with heat-killed E. aerogenes until endosymbionts were seen. Several rounds of ...
Ocugen (OCGN) announced positive preliminary efficacy and safety data from the Phase 1 dose-escalation portion of the Phase 1/2 OCU410 ArMaDa ...
The trial demonstrated MELT-300's efficacy over midazolam alone, involving over 530 patients across 13 U.S. sites. Results ...
Nov 5 (Reuters) - Fibre-optic cable provider Lumen Technologies (LUMN.N), opens new tab raised its annual free cash flow forecast on Tuesday thanks to AI deals with large cloud companies ...
US operator Lumen Technologies is attracting major big tech deals as AI services fuel demand for network capacity between datacentres It has struck a multi-faceted deal with Amazon Web Services (AWS) ...
In clinical trials involving 33 participants, the FSLED mask demonstrated a 340% improvement in deep skin elasticity compared to conventional LED masks, proving its efficacy in significantly ...